Get Premium to unlock powerful stock data
Nevro Corp logo

Nevro Corp

$ 43.62 +0.43 (+1%) 02:40 PM EST
P/E:
At Loss
P/B:
6.34
Market Cap:
$ 1.54B
Enterprise V:
$ 1.40B
Volume:
212.57K
Avg Vol (2M):
617.84K
Also Trade In:
Volume:
212.57K
Market Cap $:
1.54B
PE Ratio:
At Loss
Avg Vol (2-Month):
617.84K
Enterprise Value $:
1.40B
PB Ratio:
6.34
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Nevro Corp
NAICS : 334510 SIC : 3845
1800 Bridge Parkway, Redwood City, CA, USA, 94065
Description
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.
Name Current Vs Industry Vs History
Cash-To-Debt 1.62
Equity-to-Asset 0.45
Debt-to-Equity 0.83
Debt-to-EBITDA -1.79
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.35
Distress
Grey
Safe
Beneish M-Score -2.7
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 29.64
9-Day RSI 29.1
14-Day RSI 30.15
6-1 Month Momentum % -23.87
12-1 Month Momentum % -52.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.97
Quick Ratio 5.68
Cash Ratio 4.6
Days Inventory 264.92
Days Sales Outstanding 62.1
Days Payable 89.98

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5

Financials (Next Earnings Date:2022-08-04 Est.)

NVRO's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:NVRO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 386.137
EPS (TTM) ($) -3.9
Beta 0.98
Volatility % 38.32
14-Day RSI 30.15
14-Day ATR ($) 3.418978
20-Day SMA ($) 50.0535
12-1 Month Momentum % -52.95
52-Week Range ($) 41.74 - 182.45
Shares Outstanding (Mil) 35.26

Piotroski F-Score Details

Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nevro Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More